Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
J Natl Med Assoc. 1992 Mar; 84(3): 241–250.
PMCID: PMC2571763
PMID: 1578499

Hormone pattern in pharmacologically feminized male transsexuals in the California State prison system.

L. J. Valenta, A. N. Elias, and E. S. Domurat
Author information Copyright and License information PMC Disclaimer

Abstract

The hormonal profile of 40 transsexual inmates from a pool of 86 inmates in the California State prison system was studied before and after therapy with feminizing hormones. Clinical and social data were obtained on all 86 inmates; the incidence of human immunodeficiency virus (HIV) seropositivity was examined in 76 of the 86 individuals. Despite similar degrees of feminization in all 40 individuals in whom hormonal studies were performed, variable suppression of serum testosterone concentrations was present. Based on their testosterone concentrations while on feminizing hormone therapy, the transsexual inmates could be divided into three groups. In Group I (the "suppressed" group), the serum testosterone concentrations were markedly depressed (less than 10 ng/dL); in Group II (the "non-suppressed" group), the values of testosterone were normal (446 to 1072 ng/dL); and in Group III (the "intermediate" group), the testosterone values were between those of the suppressed group and the nonsuppressed group. We speculate that feminizing hormone therapy may induce the development of a state of target hormone resistance to testosterone that results in similar degrees of feminization independent of the circulating concentrations of testosterone. The incidence of HIV seropositivity (3/76) was considerably less than anticipated based on previous studies in populations at high risk for developing the acquired immunodeficiency syndrome.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 241
241
icon of scanned page 242
242
icon of scanned page 243
243
icon of scanned page 244
244
icon of scanned page 245
245
icon of scanned page 246
246
icon of scanned page 247
247
icon of scanned page 248
248
icon of scanned page 249
249
icon of scanned page 250
250
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Gooren L, Spinder T, Spijkstra JJ, van Kessel H, Smals A, Rao BR, Hoogslag M. Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen. J Clin Endocrinol Metab. 1987 Apr;64(4):763–770. [PubMed] [Google Scholar]
  • Goh HH, Karim SM, Ratnam SS. Recovery of hypophyseal-testicular function from sex steroid treatment and the pituitary response to castration in male transsexuals. Clin Endocrinol (Oxf) 1981 Nov;15(5):519–523. [PubMed] [Google Scholar]
  • Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 Jun;44(235):291–303. [PMC free article] [PubMed] [Google Scholar]
  • Imperato-McGinley J, Peterson RE. Male pseudohermaphroditism: the complexities of male phenotypic development. Am J Med. 1976 Aug;61(2):251–272. [PubMed] [Google Scholar]
  • Lloyd HM, Meares JD, Jacobi J, Thomas FJ. Effects of stilboestrol on growth hormone secretion and pituitary cell proliferation in the male rat. J Endocrinol. 1971 Nov;51(3):473–481. [PubMed] [Google Scholar]
  • Strickland AL, Sprinz H. Studies of the influence of estradiol and growth hormone on the hypophysectomized immature rat epiphyseal cartilage growth plate. Am J Obstet Gynecol. 1973 Feb 15;115(4):471–477. [PubMed] [Google Scholar]
  • Merimee TJ, Fineberg SE. Studies of the sex based variation of human growth hormone secretion. J Clin Endocrinol Metab. 1971 Dec;33(6):896–902. [PubMed] [Google Scholar]
  • Curran JW. The epidemiology and prevention of the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):657–662. [PubMed] [Google Scholar]
  • Jaffe HW, Hardy AM, Morgan WM, Darrow WW. The acquired immunodeficiency syndrome in gay men. Ann Intern Med. 1985 Nov;103(5):662–664. [PubMed] [Google Scholar]
  • Blattner WA, Biggar RJ, Weiss SH, Melbye M, Goedert JJ. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):665–670. [PubMed] [Google Scholar]
  • Goedert JJ, Sarngadharan MG, Biggar RJ, Weiss SH, Winn DM, Grossman RJ, Greene MH, Bodner AJ, Mann DL, Strong DM, et al. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet. 1984 Sep 29;2(8405):711–716. [PubMed] [Google Scholar]
  • Francis DP, Chin J. The prevention of acquired immunodeficiency syndrome in the United States. An objective strategy for medicine, public health, business, and the community. JAMA. 1987 Mar 13;257(10):1357–1366. [PubMed] [Google Scholar]
  • Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med. 1988 Mar 3;318(9):525–530. [PubMed] [Google Scholar]
  • Kobayashi H, Mori T, Suzuki A, Nishimura T, Nishimoto H, Harada M. Suppression of mixed lymphocyte reaction by progesterone and estradiol-17beta. Am J Obstet Gynecol. 1979 Jun 1;134(3):255–259. [PubMed] [Google Scholar]
  • Swerdloff RS, Walsh PC, Jacobs HS, Odell WD. Serum LH and FSH during sexual maturation in the male rat: effect of castration and cryptorchidism. Endocrinology. 1971 Jan;88(1):120–128. [PubMed] [Google Scholar]
  • Stern JM, Eisenfeld AJ. Distribution and metabolism of 3H-testosterone in castrated male rats; effects of cyproterone, progesterone and unlabeled testosterone. Endocrinology. 1971 May;88(5):1117–1125. [PubMed] [Google Scholar]
  • Sar M, Stumpf WE. Autoradiographic localization of radioactivity in the rat brain after the injection of 1,2-3H-testosterone. Endocrinology. 1973 Jan;92(1):251–256. [PubMed] [Google Scholar]
  • Sheridan PJ. Androgen receptors in the brain: what are we measuring? Endocr Rev. 1983 Spring;4(2):171–178. [PubMed] [Google Scholar]
  • Veldhuis JD, Sowers JR, Rogol AD, Klein FA, Miller N, Dufau ML. Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis. N Engl J Med. 1985 May 23;312(21):1371–1375. [PubMed] [Google Scholar]
  • Valenta LJ. A syndrome of functional hypogonadotropic hypogonadism and sterility in a male with elevated serum estradiol. Fertil Steril. 1977 Aug;28(8):881–884. [PubMed] [Google Scholar]
  • Lieberburg I, Maclusky NJ, McEwen BS. 5alpha-Dihydrotestosterone (DHT) receptors in rat brain and pituitary cell nuclei. Endocrinology. 1977 Feb;100(2):598–607. [PubMed] [Google Scholar]
  • Jones TM, Fang VS, Landau RL, Rosenfield R. Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab. 1978 Dec;47(6):1368–1373. [PubMed] [Google Scholar]
  • Oshima H, Sarada T, Ochiai K, Tamaoki B. Effects of a synthetic estrogen upon steroid bioconversion in vitro in testes of patients with prostatic cancer. Invest Urol. 1974 Jul;12(1):43–49. [PubMed] [Google Scholar]
  • Kalla NR, Nisula BC, Menard R, Loriaux DL. The effect of estradiol on testicular testosterone biosynthesis. Endocrinology. 1980 Jan;106(1):35–39. [PubMed] [Google Scholar]
  • Leinonen P, Ruokonen A, Kontturi M, Vihko R. Effects of estrogen treatment on human testicular unconjugated steroid and steroid sulfate production in vivo. J Clin Endocrinol Metab. 1981 Sep;53(3):569–573. [PubMed] [Google Scholar]
  • Payne AH, Jaffe RB, Abell MR. Gonadal steroid sulfates and sulfatase. 3. Correlation of human testicular sulfatase, 3beta-hydroxysteroid dehydrogenase-isomerase, histologic structure and serum testosterone. J Clin Endocrinol Metab. 1971 Oct;33(4):582–591. [PubMed] [Google Scholar]
  • Yanaihara T, Troen P, Troen BR, Troen ML. Studies of the human testis. 3. Effect of estrogen on testosterone formation in human testis in vitro. J Clin Endocrinol Metab. 1972 Jun;34(6):968–973. [PubMed] [Google Scholar]
  • Fan DF, Troen P. Studies of the human testis. VII. Conversion of pregnenolone to progesterone. J Clin Endocrinol Metab. 1975 Sep;41(3):563–574. [PubMed] [Google Scholar]
  • Saez JM, Haour F, Loras B, Sanchez P, Cathiard AM. Oestrogen induced Leydig cell refractoriness to gonadotrophin stimulation. Acta Endocrinol (Copenh) 1978 Oct;89(2):379–392. [PubMed] [Google Scholar]
  • Kalla NR, Nisula BC, Menard R, Loriaux DL. The effect of estradiol on testicular testosterone biosynthesis. Endocrinology. 1980 Jan;106(1):35–39. [PubMed] [Google Scholar]
  • GRABER AL, NEY RL, NICHOLSON WE, ISLAND DP, LIDDLE GW. NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS. J Clin Endocrinol Metab. 1965 Jan;25:11–16. [PubMed] [Google Scholar]
Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association